Top compounds associated with response to CCDC184


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.1
mRNA Parthenolide CTRPv2 pan-cancer AAC -0.065 0.1
mRNA bendamustine CTRPv2 pan-cancer AAC -0.063 0.1
mRNA SR-II-138A CTRPv2 pan-cancer AAC 0.053 0.1
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC -0.062 0.1
mRNA FR-180204 GDSC1000 pan-cancer AAC -0.055 0.1
mRNA paclitaxel GDSC1000 pan-cancer AAC -0.083 0.1
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.056 0.1
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.1
mRNA TG-101348 GDSC1000 pan-cancer AAC -0.045 0.1
Download CSV